FDA Approves First Treatment for Genetic Metabolic Disorder Including Hurler Disorder - 4/30/2003

FDA Approves First Treatment for Fabry Disease - 4/24/2003

FDA Statement on Counterfeit Procrit - 3/11/2003

FDA Approves First Biologic Therapy for Psoriasis - 1/31/2003

FDA Approves BOTOX To Treat Frown Lines - 4/15/2002

FDA Approves First Radiopharmaceutical Product to Treat Non-Hodgkin's Lymphoma - 2/20/2002

FDA Approves First Biologic Treatment for Sepsis - 11/21/2001

FDA Approves Stand-Alone Package of Ribavirin for Combination Therapy with Intron A for Treatment of Chronic Hepatitis C Infection - 7/26/2001

Serious Manufacturing Deficiencies with Abbokinase Prompt FDA Letter to Abbott Labs - 7/16/1999

FDA Approves Novel Treatment for Rare Form of Cancer - Denileukin diftitox (Ontak), Seragen, Inc. - 2/5/1999

First Biotechnology Product for Arthritis Approved - HHS News - Etanercept (Enbrel), Immunex Corp. - 11/2/1998

New Monoclonal Antibody Approved for Advanced Breast Cancer - HHS News - Trastuzumab (Herceptin), Genentech, Inc. - 9/25/1998

First Treatment for Crohn's Disease Approved - HHS News - Infliximab (Remicade), Centecor, Inc. - 8/24/1998

FDA Licenses Biotech Product to Prevent Serious RSV Disease - Palivizumab (Synagis), MedImmune, Inc. - 6/19/1998

FDA Clears New Hepatitis C Treatment for Marketing - 6/3/1998

New Biotech Product for Diabetic Ulcers - Becaplermin (Regranex), OMJ Pharmaceuticals, Inc. - 12/16/1997

New Biotechnology Product Approved to Help Prevent Rejection of Kidney Transplants - Daclizumab (Zenapax), Hoffman-La Roche Inc. - 12/11/1997

First Monoclonal Antibody Approved to Treat Cancer - Rituximab (Rituxan), Genentech, Inc. - 11/26/1997

New Biotech Product Approved to Reduce Need for Chemotherapy-Related Platelet Transfusions - Oprelvekin (Neumega), Genetics Institute, Inc. - 11/25/1997